Javascript must be enabled to continue!
Alpha‐Synuclein Demonstrates Varying Binding Affinities With Different Tau Isoforms
View through CrossRef
ABSTRACTThe hallmark of various neurodegenerative diseases is the accumulation and aggregation of amyloidogenic proteins, such as amyloid‐beta (Aβ) and tau in Alzheimer's disease (AD) and alpha‐synuclein (aSyn) in synucleinopathies. Many neurodegenerative diseases express mixed pathology. For instance, Lewy bodies are reported in tauopathies and neurofibrillary tau‐tangles are detected in synucleinopathies, suggesting a potential co‐existence or crosstalk of misfolded aSyn and tau. In the present study, we investigated the binding characteristics of monomeric aSyn with different tau isoforms by using surface plasmon resonance (SPR) spectroscopy allowing monitoring direct protein–protein interactions and their potential co‐localization using SH‐SY5Y cells. The calculation of the binding parameters (association and dissociation rate constants) indicated the strongest binding affinity between aSyn and tau isoform 1N3R followed by tau 2N3R and tau 2N4R. Co‐localization studies in SH‐SY5Y cells, treated with aSyn and all six tau isoforms revealed an intracellular co‐localization of aSyn with different isoforms of tau. Subcellular fractionation confirmed the cellular uptake and colocalization of tau and aSyn in the same compartment, showing their expression in membrane, nuclear, and cytoskeletal fractions. Understanding the intricate interplay between aSyn and tau is crucial for unraveling the pathophysiology of PD, AD, and related neurodegenerative disorders, ultimately paving the way for the development of effective treatments targeting this interaction. In conclusion, our data indicate that aSyn and tau are direct interaction partners with varying binding affinities depending on the tau isoform. This interaction may be significant for understanding the pathophysiology of dementia with mixed pathologies.image
Title: Alpha‐Synuclein Demonstrates Varying Binding Affinities With Different Tau Isoforms
Description:
ABSTRACTThe hallmark of various neurodegenerative diseases is the accumulation and aggregation of amyloidogenic proteins, such as amyloid‐beta (Aβ) and tau in Alzheimer's disease (AD) and alpha‐synuclein (aSyn) in synucleinopathies.
Many neurodegenerative diseases express mixed pathology.
For instance, Lewy bodies are reported in tauopathies and neurofibrillary tau‐tangles are detected in synucleinopathies, suggesting a potential co‐existence or crosstalk of misfolded aSyn and tau.
In the present study, we investigated the binding characteristics of monomeric aSyn with different tau isoforms by using surface plasmon resonance (SPR) spectroscopy allowing monitoring direct protein–protein interactions and their potential co‐localization using SH‐SY5Y cells.
The calculation of the binding parameters (association and dissociation rate constants) indicated the strongest binding affinity between aSyn and tau isoform 1N3R followed by tau 2N3R and tau 2N4R.
Co‐localization studies in SH‐SY5Y cells, treated with aSyn and all six tau isoforms revealed an intracellular co‐localization of aSyn with different isoforms of tau.
Subcellular fractionation confirmed the cellular uptake and colocalization of tau and aSyn in the same compartment, showing their expression in membrane, nuclear, and cytoskeletal fractions.
Understanding the intricate interplay between aSyn and tau is crucial for unraveling the pathophysiology of PD, AD, and related neurodegenerative disorders, ultimately paving the way for the development of effective treatments targeting this interaction.
In conclusion, our data indicate that aSyn and tau are direct interaction partners with varying binding affinities depending on the tau isoform.
This interaction may be significant for understanding the pathophysiology of dementia with mixed pathologies.
image.
Related Results
L᾽«unilinguisme» officiel de Constantinople byzantine (VIIe-XIIe s.)
L᾽«unilinguisme» officiel de Constantinople byzantine (VIIe-XIIe s.)
<p>Νίκος Οικονομίδης</...
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
<span style="font-size: 11pt; color: black; font-family: 'Times New Roman','serif'">ΠΗΛΙΝΑ ΙΓ&Delta...
Un manoscritto equivocato del copista santo Theophilos († 1548)
Un manoscritto equivocato del copista santo Theophilos († 1548)
<p><font size="3"><span class="A1"><span style="font-family: 'Times New Roman','serif'">ΕΝΑ ΛΑΝ&...
Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi Regulate
the Brain Tau Hyperphosphorylation at Multiple Sites Induced by
Composited Aβ in Rats
Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi Regulate
the Brain Tau Hyperphosphorylation at Multiple Sites Induced by
Composited Aβ in Rats
Background:
Neurofibrillary Tangles (NFTs), formed by hyperphosphorylation of Tau
protein in Alzheimer's Disease (AD), arethe main pathomechanisms of neuronal degeneration,
which i...
Novel β-synuclein Rearrangements in tumor
Novel β-synuclein Rearrangements in tumor
Abstract
Purpose
The synuclein family includes a-, b-, g-synuclein and is predominantly expressed in neurons. a- and b-synuclein is mutated in Parkinson's disease and demen...
Severe oligomeric tau toxicity can be reversed without long-term sequelae
Severe oligomeric tau toxicity can be reversed without long-term sequelae
Abstract
Tau is a microtubule stabilizing protein that forms abnormal aggregates in many neurodegenerative disorders, including Alzheimer’s disease. We have previous...
Tau associates with protein tyrosine phosphatase SHP2
Tau associates with protein tyrosine phosphatase SHP2
<p>The microtubule-associated protein tau normally functions to bind to and stabilize microtubules. However, evidence now indicates that tau may also play a critical role in ...
Clinical stage Alzheimer’s therapy, NNI‐362 promotes TH+ neurons associated with a reversal of motor deficits in AAV‐alpha synuclein model, leaving alpha synuclein unchanged
Clinical stage Alzheimer’s therapy, NNI‐362 promotes TH+ neurons associated with a reversal of motor deficits in AAV‐alpha synuclein model, leaving alpha synuclein unchanged
AbstractBackgroundNNI‐362 is a novel small molecule identified by phenotypic screening to discover compounds that promote new neurons from human neural progenitor cells and have ne...

